Elbonix 50 mg (Eltrombopag)
Elbonix is an orally bioavailable, small-molecule TPO-receptor agonist that interacts with the transmembrane domain of the human TPO-receptor and initiates signaling cascades that induce proliferation and differentiation from bone marrow progenitor cells. Elbonix is available in tablet form for oral administration.
Product Features:
• Improves chronic ITP & SAA effectively
• Effective in chronic hepatitis C-related thrombocytopenia
• Increases & maintains platelet counts
Product Name: Elbonix
Generic Name : Eltrombopag Olamine
Formulation: Tablet
Available Pack Size : 4×7 ’s and 4×7’s
Available Strengths: 25 mg and 50 mg
Categories: Hematopoietic
Manufacturer: Beacon Pharmaceuticals Ltd.
